ADMEDUS under the leadership of Wayne Paterson has been transformed into a
significant player in the multi-billion dollar cardiac device industry, using the unique ADAPT TECHNOLOGY which is scientifically PROVEN beyond doubt.
ADMEDUS overnight transformed from a single flat patch to a 3D curved patch and tissue
moulding capabilities, merging their technologies has made ADMEDUS
far superior to its competitors. Making ADMEDUS a disruptive technology and the leading
BIO TISSUE SPECIALIST. And a target for a takeover.
Ann: Appendix 4C - quarterly, page-150
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
0.000(0.00%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.80 | $96.66K | 9.794K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 286 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.99 | 198 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |